logo

EDIT

Editas MedicineยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

EDIT Profile

Editas Medicine, Inc.

A leading genome editing company pioneering CRISPR technology for treating serious diseases

Biological Technology
--
02/03/2016
NASDAQ Stock Exchange
246
12-31
Common stock
11 Hurley Street , Cambridge , Massachusetts 02141
--
Editas Medicine, Inc., was founded in September 2013 as Gengine, Inc., and later changed its name to Editas Medicine, Inc., in November 2013. The company is a leading genetic research company dedicated to treating gene-related diseases by correcting patients' disease-causing genes.